 Shaodong Dai
Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, T-Cell | 9 | 2022 | 702 | 2.180 |
Why?
| | CD4-Positive T-Lymphocytes | 12 | 2022 | 1045 | 1.810 |
Why?
| | Nickel | 4 | 2021 | 54 | 1.800 |
Why?
| | Hypersensitivity | 7 | 2021 | 249 | 1.670 |
Why?
| | Autoantigens | 7 | 2022 | 416 | 1.200 |
Why?
| | Prosthesis Failure | 2 | 2021 | 114 | 1.200 |
Why?
| | Peptides | 11 | 2022 | 915 | 1.170 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 5 | 2022 | 334 | 1.100 |
Why?
| | Histocompatibility Antigens Class II | 5 | 2022 | 360 | 1.070 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2022 | 3626 | 0.960 |
Why?
| | Berylliosis | 5 | 2016 | 184 | 0.940 |
Why?
| | Models, Molecular | 23 | 2021 | 1484 | 0.890 |
Why?
| | Haptens | 2 | 2021 | 20 | 0.830 |
Why?
| | T-Lymphocytes | 7 | 2021 | 1923 | 0.780 |
Why?
| | Peptide Fragments | 4 | 2020 | 688 | 0.760 |
Why?
| | Insulin | 4 | 2022 | 2316 | 0.750 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2022 | 842 | 0.750 |
Why?
| | Joint Prosthesis | 1 | 2021 | 18 | 0.720 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2022 | 175 | 0.710 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 179 | 0.690 |
Why?
| | Mice, Inbred NOD | 7 | 2022 | 586 | 0.690 |
Why?
| | Epitopes | 3 | 2017 | 466 | 0.690 |
Why?
| | Bryostatins | 1 | 2020 | 1 | 0.680 |
Why?
| | Protein Conformation | 13 | 2021 | 854 | 0.600 |
Why?
| | Arthroplasty, Replacement | 2 | 2020 | 37 | 0.580 |
Why?
| | Echinococcus granulosus | 1 | 2017 | 1 | 0.570 |
Why?
| | Organogold Compounds | 1 | 2017 | 5 | 0.570 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2017 | 17 | 0.560 |
Why?
| | Protein Processing, Post-Translational | 4 | 2018 | 453 | 0.550 |
Why?
| | Multienzyme Complexes | 1 | 2017 | 68 | 0.550 |
Why?
| | Machine Learning | 1 | 2022 | 444 | 0.540 |
Why?
| | Epitopes, T-Lymphocyte | 4 | 2021 | 185 | 0.500 |
Why?
| | Transcriptome | 2 | 2020 | 883 | 0.500 |
Why?
| | Amino Acid Sequence | 10 | 2019 | 2044 | 0.450 |
Why?
| | HLA-DR Antigens | 2 | 2020 | 224 | 0.440 |
Why?
| | HLA-DP beta-Chains | 5 | 2016 | 82 | 0.430 |
Why?
| | HLA-DP Antigens | 2 | 2010 | 32 | 0.420 |
Why?
| | Protein Binding | 13 | 2020 | 2110 | 0.420 |
Why?
| | Co-Repressor Proteins | 2 | 2023 | 16 | 0.400 |
Why?
| | Animals | 28 | 2024 | 34647 | 0.400 |
Why?
| | Beryllium | 4 | 2016 | 150 | 0.390 |
Why?
| | Arthropod Proteins | 1 | 2012 | 4 | 0.390 |
Why?
| | Aprotinin | 1 | 2012 | 9 | 0.390 |
Why?
| | Salivary Proteins and Peptides | 1 | 2012 | 13 | 0.390 |
Why?
| | Ticks | 1 | 2012 | 19 | 0.380 |
Why?
| | Crystallography, X-Ray | 11 | 2018 | 434 | 0.380 |
Why?
| | Ixodes | 1 | 2012 | 14 | 0.380 |
Why?
| | Metals | 1 | 2013 | 126 | 0.380 |
Why?
| | Mice | 20 | 2022 | 16620 | 0.380 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1705 | 0.380 |
Why?
| | Histocompatibility Antigen H-2D | 2 | 2022 | 21 | 0.380 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2012 | 70 | 0.380 |
Why?
| | Evolution, Molecular | 2 | 2012 | 465 | 0.340 |
Why?
| | Alleles | 3 | 2010 | 842 | 0.330 |
Why?
| | Binding Sites | 6 | 2017 | 1244 | 0.320 |
Why?
| | Ferredoxins | 1 | 2007 | 4 | 0.280 |
Why?
| | Iron-Sulfur Proteins | 1 | 2007 | 26 | 0.280 |
Why?
| | Protein Structure, Tertiary | 8 | 2012 | 837 | 0.280 |
Why?
| | Oxidoreductases | 1 | 2007 | 89 | 0.270 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2822 | 0.260 |
Why?
| | Humans | 29 | 2023 | 128499 | 0.250 |
Why?
| | HIV Infections | 1 | 2020 | 2711 | 0.240 |
Why?
| | Antigens | 2 | 2020 | 353 | 0.230 |
Why?
| | Hybridomas | 3 | 2021 | 234 | 0.230 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 60 | 0.220 |
Why?
| | DNA-Binding Proteins | 4 | 2023 | 1423 | 0.210 |
Why?
| | Hydrogen Bonding | 2 | 2017 | 149 | 0.210 |
Why?
| | Molecular Conformation | 2 | 2022 | 142 | 0.210 |
Why?
| | Amino Acids | 2 | 2022 | 477 | 0.210 |
Why?
| | HLA-DR Serological Subtypes | 2 | 2013 | 4 | 0.210 |
Why?
| | Nucleic Acids | 1 | 2024 | 60 | 0.210 |
Why?
| | Oxygenases | 1 | 2002 | 10 | 0.210 |
Why?
| | Polychlorinated Biphenyls | 1 | 2002 | 9 | 0.210 |
Why?
| | Disulfides | 2 | 2022 | 97 | 0.210 |
Why?
| | Receptors, Steroid | 1 | 2023 | 49 | 0.200 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2022 | 7 | 0.200 |
Why?
| | Dioxygenases | 1 | 2002 | 29 | 0.200 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2022 | 40 | 0.200 |
Why?
| | Hepatitis B virus | 1 | 2022 | 35 | 0.200 |
Why?
| | AlkB Enzymes | 1 | 2022 | 1 | 0.200 |
Why?
| | Hirudo medicinalis | 1 | 2022 | 1 | 0.200 |
Why?
| | Leeches | 1 | 2022 | 2 | 0.190 |
Why?
| | Germ Cells | 1 | 2022 | 59 | 0.190 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2022 | 46 | 0.190 |
Why?
| | Rift Valley fever virus | 1 | 2021 | 2 | 0.190 |
Why?
| | Histones | 3 | 2018 | 588 | 0.190 |
Why?
| | Support Vector Machine | 1 | 2022 | 37 | 0.190 |
Why?
| | Bacterial Proteins | 4 | 2018 | 833 | 0.190 |
Why?
| | Aspergillus nidulans | 1 | 2021 | 6 | 0.190 |
Why?
| | Transglutaminases | 1 | 2022 | 153 | 0.190 |
Why?
| | Protein Structure, Secondary | 3 | 2012 | 340 | 0.180 |
Why?
| | VDJ Exons | 1 | 2021 | 2 | 0.180 |
Why?
| | Early Growth Response Protein 2 | 1 | 2020 | 10 | 0.180 |
Why?
| | Glycoproteins | 2 | 2014 | 337 | 0.180 |
Why?
| | Sequence Alignment | 3 | 2012 | 330 | 0.180 |
Why?
| | GATA2 Transcription Factor | 1 | 2020 | 14 | 0.180 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 32 | 0.180 |
Why?
| | Environmental Pollutants | 1 | 2002 | 142 | 0.180 |
Why?
| | HLA-DRB4 Chains | 1 | 2020 | 6 | 0.170 |
Why?
| | STAT5 Transcription Factor | 1 | 2020 | 48 | 0.170 |
Why?
| | Muromegalovirus | 1 | 2020 | 21 | 0.170 |
Why?
| | Transcription Factor AP-1 | 1 | 2020 | 85 | 0.170 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 170 | 0.170 |
Why?
| | NFATC Transcription Factors | 1 | 2020 | 79 | 0.170 |
Why?
| | Response Elements | 1 | 2020 | 89 | 0.170 |
Why?
| | Mutation | 5 | 2020 | 3696 | 0.170 |
Why?
| | Toxoplasmosis | 1 | 2020 | 36 | 0.170 |
Why?
| | Toxoplasma | 1 | 2020 | 38 | 0.170 |
Why?
| | Amino Acid Motifs | 4 | 2021 | 211 | 0.170 |
Why?
| | Trace Elements | 1 | 2020 | 47 | 0.170 |
Why?
| | Interleukin-13 | 1 | 2020 | 144 | 0.160 |
Why?
| | Cell Cycle Checkpoints | 1 | 2020 | 95 | 0.160 |
Why?
| | Mast Cells | 1 | 2020 | 141 | 0.160 |
Why?
| | Major Histocompatibility Complex | 3 | 2013 | 229 | 0.160 |
Why?
| | Virus Latency | 1 | 2020 | 78 | 0.160 |
Why?
| | Sarcoidosis | 1 | 2021 | 155 | 0.160 |
Why?
| | Herpesviridae Infections | 1 | 2020 | 134 | 0.160 |
Why?
| | Purines | 1 | 2020 | 169 | 0.150 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2018 | 24 | 0.150 |
Why?
| | Molecular Docking Simulation | 1 | 2019 | 109 | 0.150 |
Why?
| | Chronic Disease | 3 | 2020 | 1692 | 0.150 |
Why?
| | Antigens, Neoplasm | 1 | 2021 | 308 | 0.150 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2018 | 56 | 0.150 |
Why?
| | Antigen Presentation | 3 | 2020 | 205 | 0.150 |
Why?
| | Protein Kinase C | 1 | 2020 | 257 | 0.150 |
Why?
| | Lysosomes | 1 | 2019 | 135 | 0.150 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 276 | 0.150 |
Why?
| | Enzyme Inhibitors | 2 | 2017 | 813 | 0.150 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 581 | 0.150 |
Why?
| | Histone Demethylases | 1 | 2018 | 31 | 0.140 |
Why?
| | Thymus Gland | 1 | 2019 | 309 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2021 | 775 | 0.140 |
Why?
| | Autoimmunity | 2 | 2014 | 860 | 0.140 |
Why?
| | Protein Domains | 1 | 2019 | 252 | 0.140 |
Why?
| | Helminth Proteins | 1 | 2017 | 19 | 0.140 |
Why?
| | Glutaredoxins | 1 | 2017 | 12 | 0.140 |
Why?
| | Cytidine Deaminase | 1 | 2017 | 57 | 0.140 |
Why?
| | Insecta | 1 | 2017 | 64 | 0.140 |
Why?
| | Up-Regulation | 1 | 2020 | 823 | 0.130 |
Why?
| | Pancreas | 1 | 2019 | 306 | 0.130 |
Why?
| | Immune Tolerance | 1 | 2019 | 350 | 0.130 |
Why?
| | Lymphocyte Activation | 3 | 2010 | 1098 | 0.130 |
Why?
| | Antiviral Agents | 1 | 2022 | 711 | 0.130 |
Why?
| | Pyrimidines | 1 | 2020 | 449 | 0.130 |
Why?
| | Kinetics | 3 | 2012 | 1624 | 0.130 |
Why?
| | Protein Folding | 1 | 2017 | 266 | 0.130 |
Why?
| | Cysteine | 1 | 2017 | 183 | 0.130 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 508 | 0.130 |
Why?
| | Catalytic Domain | 3 | 2021 | 217 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 3 | 2016 | 2269 | 0.120 |
Why?
| | Chromogranin A | 1 | 2015 | 42 | 0.120 |
Why?
| | Cell Line, Tumor | 2 | 2021 | 3178 | 0.120 |
Why?
| | Cancer Vaccines | 2 | 2021 | 163 | 0.120 |
Why?
| | Conserved Sequence | 2 | 2021 | 227 | 0.110 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1404 | 0.110 |
Why?
| | HIV-1 | 1 | 2020 | 834 | 0.110 |
Why?
| | DNA | 4 | 2024 | 1394 | 0.110 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2516 | 0.110 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1357 | 0.100 |
Why?
| | Phosphoproteins | 1 | 2014 | 329 | 0.100 |
Why?
| | Cross Reactions | 2 | 2011 | 129 | 0.090 |
Why?
| | Blood | 1 | 2012 | 100 | 0.090 |
Why?
| | H-2 Antigens | 1 | 2011 | 115 | 0.090 |
Why?
| | Multigene Family | 1 | 2012 | 198 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1227 | 0.090 |
Why?
| | Mice, Transgenic | 4 | 2021 | 2069 | 0.090 |
Why?
| | Ligands | 4 | 2020 | 617 | 0.090 |
Why?
| | Lipids | 1 | 2014 | 621 | 0.090 |
Why?
| | Aged | 2 | 2022 | 21976 | 0.090 |
Why?
| | RNA | 2 | 2022 | 881 | 0.080 |
Why?
| | Lysine | 1 | 2012 | 285 | 0.080 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 64 | 0.080 |
Why?
| | Oxidation-Reduction | 2 | 2018 | 1003 | 0.080 |
Why?
| | Allergens | 1 | 2013 | 382 | 0.080 |
Why?
| | bcl-X Protein | 2 | 2006 | 42 | 0.080 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2021 | 138 | 0.080 |
Why?
| | Signal Transduction | 2 | 2020 | 4825 | 0.080 |
Why?
| | bcl-2-Associated X Protein | 2 | 2006 | 48 | 0.080 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 112 | 0.080 |
Why?
| | Carrier Proteins | 2 | 2023 | 732 | 0.080 |
Why?
| | Membrane Proteins | 3 | 2006 | 1109 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2014 | 803 | 0.080 |
Why?
| | Glutamic Acid | 1 | 2010 | 228 | 0.070 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 122 | 0.070 |
Why?
| | Spinacia oleracea | 1 | 2007 | 7 | 0.070 |
Why?
| | Surface Plasmon Resonance | 1 | 2008 | 88 | 0.070 |
Why?
| | Synechocystis | 1 | 2007 | 3 | 0.070 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 10 | 0.070 |
Why?
| | Thioredoxins | 1 | 2007 | 28 | 0.070 |
Why?
| | Histocompatibility Antigens | 1 | 2008 | 107 | 0.070 |
Why?
| | Electron Transport | 1 | 2007 | 112 | 0.070 |
Why?
| | Plant Proteins | 1 | 2007 | 88 | 0.070 |
Why?
| | Cohort Studies | 1 | 2017 | 5402 | 0.070 |
Why?
| | Burkholderia | 1 | 2006 | 13 | 0.070 |
Why?
| | Methylation | 3 | 2018 | 227 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2012 | 619 | 0.060 |
Why?
| | Hydrolases | 1 | 2006 | 56 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 539 | 0.060 |
Why?
| | Phenols | 1 | 2006 | 97 | 0.060 |
Why?
| | Female | 4 | 2021 | 68268 | 0.060 |
Why?
| | Complementarity Determining Regions | 3 | 2011 | 49 | 0.060 |
Why?
| | Iron | 1 | 2007 | 282 | 0.060 |
Why?
| | Demethylation | 1 | 2024 | 4 | 0.060 |
Why?
| | Recombinant Proteins | 1 | 2007 | 1291 | 0.060 |
Why?
| | Meiosis | 1 | 2024 | 63 | 0.050 |
Why?
| | Lung Diseases | 1 | 2010 | 715 | 0.050 |
Why?
| | Biodegradation, Environmental | 1 | 2002 | 82 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2003 | 160 | 0.050 |
Why?
| | Macromolecular Substances | 1 | 2002 | 213 | 0.050 |
Why?
| | Cytochrome c Group | 1 | 2002 | 42 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 229 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 636 | 0.050 |
Why?
| | Mammals | 1 | 2024 | 269 | 0.050 |
Why?
| | Chemical Phenomena | 1 | 2021 | 81 | 0.050 |
Why?
| | Catalysis | 1 | 2002 | 306 | 0.050 |
Why?
| | Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| | Antigens, Fungal | 1 | 2021 | 27 | 0.050 |
Why?
| | Spodoptera | 1 | 2021 | 37 | 0.050 |
Why?
| | Interferon Type I | 1 | 2022 | 140 | 0.050 |
Why?
| | HLA-DR3 Antigen | 1 | 2021 | 80 | 0.050 |
Why?
| | Base Sequence | 2 | 2015 | 2137 | 0.050 |
Why?
| | Interleukin-2 | 2 | 2015 | 434 | 0.050 |
Why?
| | Models, Chemical | 1 | 2002 | 263 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2023 | 356 | 0.040 |
Why?
| | Fungal Proteins | 1 | 2021 | 128 | 0.040 |
Why?
| | Transcription Factors | 2 | 2006 | 1635 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2021 | 178 | 0.040 |
Why?
| | Antigens, Protozoan | 1 | 2020 | 22 | 0.040 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2020 | 51 | 0.040 |
Why?
| | Crystallization | 2 | 2015 | 137 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2024 | 291 | 0.040 |
Why?
| | Disease Resistance | 1 | 2020 | 31 | 0.040 |
Why?
| | Immediate-Early Proteins | 1 | 2020 | 51 | 0.040 |
Why?
| | Escherichia coli Proteins | 1 | 2022 | 177 | 0.040 |
Why?
| | DNA Repair | 1 | 2022 | 206 | 0.040 |
Why?
| | Middle Aged | 2 | 2021 | 30923 | 0.040 |
Why?
| | Protozoan Proteins | 1 | 2020 | 74 | 0.040 |
Why?
| | Antibody Affinity | 1 | 2020 | 59 | 0.040 |
Why?
| | Cell Line | 2 | 2020 | 2741 | 0.040 |
Why?
| | Genome | 1 | 2022 | 277 | 0.040 |
Why?
| | Antibody Specificity | 1 | 2020 | 182 | 0.040 |
Why?
| | Viral Proteins | 1 | 2021 | 323 | 0.040 |
Why?
| | Guanosine Tetraphosphate | 1 | 2018 | 4 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2003 | 436 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2015 | 1142 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2020 | 4017 | 0.040 |
Why?
| | Adult | 2 | 2021 | 35302 | 0.040 |
Why?
| | Unfolded Protein Response | 1 | 2018 | 53 | 0.040 |
Why?
| | Genes, Bacterial | 1 | 2018 | 158 | 0.040 |
Why?
| | Salmonella | 1 | 2018 | 59 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1187 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2011 | 359 | 0.040 |
Why?
| | Apoptosis | 1 | 2006 | 2437 | 0.040 |
Why?
| | Protein Denaturation | 1 | 2017 | 75 | 0.040 |
Why?
| | RNA, Bacterial | 1 | 2018 | 183 | 0.040 |
Why?
| | Proteolysis | 1 | 2018 | 162 | 0.030 |
Why?
| | Proline | 1 | 2017 | 76 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 614 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2021 | 844 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2018 | 310 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2018 | 797 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 715 | 0.030 |
Why?
| | Substrate Specificity | 2 | 2010 | 366 | 0.030 |
Why?
| | Arginine | 1 | 2018 | 260 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 936 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5281 | 0.030 |
Why?
| | Baculoviridae | 1 | 2015 | 44 | 0.030 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2006 | 38 | 0.030 |
Why?
| | Male | 2 | 2021 | 63045 | 0.030 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2006 | 181 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3339 | 0.030 |
Why?
| | DNA Primers | 1 | 2014 | 510 | 0.030 |
Why?
| | Sodium | 1 | 2014 | 202 | 0.030 |
Why?
| | Lung | 2 | 2016 | 3748 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1191 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2014 | 683 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 2 | 2006 | 633 | 0.020 |
Why?
| | HLA Antigens | 1 | 2013 | 234 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2011 | 57 | 0.020 |
Why?
| | Leukemia, Experimental | 1 | 2010 | 27 | 0.020 |
Why?
| | Genes, MHC Class I | 1 | 2010 | 33 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 46 | 0.020 |
Why?
| | Binding, Competitive | 1 | 2010 | 204 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 83 | 0.020 |
Why?
| | Vaccines, Synthetic | 1 | 2010 | 126 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 114 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2010 | 647 | 0.020 |
Why?
| | Germ-Line Mutation | 1 | 2009 | 138 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 385 | 0.020 |
Why?
| | Yersinia enterocolitica | 1 | 2007 | 7 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 370 | 0.020 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2006 | 15 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 706 | 0.020 |
Why?
| | Enterotoxins | 1 | 2006 | 89 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 157 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2010 | 524 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2006 | 95 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2006 | 107 | 0.020 |
Why?
| | Immunotherapy | 1 | 2010 | 589 | 0.020 |
Why?
| | Point Mutation | 1 | 2006 | 225 | 0.010 |
Why?
| | Transfection | 1 | 2006 | 896 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2345 | 0.010 |
Why?
| | B-Cell Activation Factor Receptor | 1 | 2003 | 13 | 0.010 |
Why?
| | B-Cell Activating Factor | 1 | 2003 | 20 | 0.010 |
Why?
| | Neuropeptides | 1 | 2003 | 71 | 0.010 |
Why?
| | Solubility | 1 | 2003 | 234 | 0.010 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 186 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2003 | 324 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 369 | 0.010 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2003 | 325 | 0.010 |
Why?
| | Computer Simulation | 1 | 2003 | 939 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2003 | 658 | 0.010 |
Why?
|
|
Dai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|